IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs

Autoantibodies-abzymes hydrolyzing DNA, myelin basic protein, and oligosaccharides have been revealed in the sera of patients with multiple sclerosis (MS). In MS, specific microRNAs are found in blood and cerebrospinal fluid, which are characterized by increased expression. Autoantibodies, specifically hydrolyzing four different miRNAs, were first detected in the blood of schizophrenia patients. Here, we present the first evidence that 23 IgG antibodies of MS patients effectively recognize and hydrolyze four neuroregulatory miRNAs (miR-137, miR-9-5p, miR-219-2-3p, and miR-219-5p) and four immunoregulatory miRNAs (miR-21-3p, miR-146a-3p, miR-155-5p, and miR-326). Several known criteria were checked to show that the recognition and hydrolysis of miRNAs is an intrinsic property of MS IgGs. The hydrolysis of all miRNAs is mostly site-specific. The major and moderate sites of the hydrolysis of each miRNA for most of the IgG preparations coincided; however, some of them showed other specific sites of splitting. Several individual IgGs hydrolyzed some miRNAs almost nonspecifically at nearly all internucleoside bonds or demonstrated a combination of site-specific and nonspecific splitting. Maximum average relative activity (RA) was observed in the hydrolysis of miR-155-5p for IgGs of patients of two types of MS—clinically isolated syndrome and relapsing-remitting MS—but was also high for patients with primary progressive and secondary progressive MS. Differences between RAs of IgGs of four groups of MS patients and healthy donors were statistically significant (p < 0.015). There was a tendency of decreasing efficiency of hydrolysis of all eight miRNAs during remission compared with the exacerbation of the disease.     

基于多学习单元卷积神经网络的雷达辐射源信号识别

现有基于人工提取特征的复杂体制雷达辐射源信号识别方法时效性低,识别准确率不佳. 为此,提出了一种基于多学习单元卷积神经网络的识别方法. 首先对辐射源信号的模糊函数进行高斯平滑,以校正噪声带来的毛刺与畸变;然后提取其正交切片作为进一步的特征提取对象;最后构建多学习单元卷积神经网络,学习和提取正交切片深层、泛在的特征,并通过softmax分类器进行分类识别. 仿真实验结果表明,所提方法在信噪比为-2 dB时对6类典型雷达信号的整体平均识别率均保持在99.86%以上,即便是在-6 dB环境中,雷达信号的识别率也可达到88.50%,在极低信噪比条件下具有良好的性能和可行性.     

基于动态模式分解的移动用户信道容量预测算法

在多输入多输出环境下,为了能够连续预测出移动用户的信道容量并以此合理地分配用户资源,提出了一种基于动态模式分解（DMD）的信道容量预测方法及其优化方法：基于经验模态分解的选择性归一化动态模式分解（ESN-DMD）.仿真结果表明,DMD算法只适用于预测低移速低复杂度的用户信号,ESN-DMD算法可以预测不同移速的用户信道容量.     

水下设备安装过程及其影响因素分析

为了提高水下设备安装精度与工作效率,基于海上工作经验及查阅国内外相关文献,对水下设备的安装过程进行了研究,其总体过程大致分为5个阶段,即装船固定、提升操作、穿越飞溅区、深水下放、落地坐放;分析了影响水下设备安装过程的主要因素,其中水深主要影响吊放系统和设备在水下的横向偏移;波浪载荷主要应用船舶的动态响应,在设备经历穿越飞溅区阶段时对设备及缆绳造成损伤的风险较大;水下设备自身参数主要影响安装方式和安装船舶的选用。     

考虑限制性卖空的多期模糊投资组合优化模型

在实际证券交易中, 卖空操作是一种重要的投资手段, 因此本文研究考虑限制性卖空的多期模糊投资组合优化问题。将风险资产的收益视为梯形模糊数。在允许卖空的情况下, 建立了带单期最低期望收益约束、破产控制约束和投资比例边界约束的多期可信性均值−下半方差−偏度投资组合优化模型。设计了一个改进的多种群粒子群算法对模型进行求解。最后, 采用真实股票数据进行数值算例分析, 说明了所提出的优化模型和算法的有效性。     

高温高湿盐环境下SBS改性沥青胶浆的高温性能

基于自行设计的室内盐蚀干湿循环试验,采用动态剪切流变仪,对SBS改性沥青胶浆进行温度扫描试验和多重应力重复蠕变恢复(MSCR)试验. 以3.2 kPa应力下的不可恢复蠕变柔量J_nr,3.2为胶浆高温流变性能评价指标,分析试验环境和干湿循环耦合作用对胶浆流变性能的影响. 采用灰色关联理论,探究J_nr,3.2与常规流变参数、干湿循环次数及试验环境之间的关联性. 结果表明,随着盐蚀干湿循环次数的增加,胶浆的复数切变模量、车辙因子及J_nr,3.2均呈增大趋势,相位角和蠕变恢复率呈减小趋势. 在同种试验条件下,硫酸盐环境对胶浆高温性能的影响最大. J_nr,3.2与改进型车辙因子、试验环境的灰色关联度最大,关联度系数均大于0.93. 建议采用日常清扫、定期洒水冲洗的方式来减小路面盐分的积累,提高高温高湿环境中沥青路面的抵抗变形的能力.     

一种引入通信的多移动机器人编队方法*

提出以视觉跟踪为基础并引入通信进行多机器人的编队控制方法,根据需要编写了一种新的通信协议,采用闭环l-Φ实现编队算法.这种多机器人编队控制避免了视觉系统的局限,能够更好地在复杂未知环境中协作完成任务,解决了编队控制的无反馈和实时性不高的问题,使得机器人能够准确迅速地进行跟踪和通信编队,一起顺利达到目标点.试验结果证明了该方法的有效性.     

A Novel Volume-Stable Collagen Matrix Induces Changes in the Behavior of Primary Human Oral Fibroblasts,Periodontal Ligament,and Endothelial Cells

The aim of the present study was to investigate the influence of a novel volume-stable collagen matrix (vCM) on early wound healing events including cellular migration and adhesion, protein adsorption and release, and the dynamics of the hemostatic system. For this purpose, we utilized transwell migration and crystal violet adhesion assays, ELISAs for quantification of adsorbed and released from the matrix growth factors, and qRT-PCR for quantification of gene expression in cells grown on the matrix. Our results demonstrated that primary human oral fibroblasts, periodontal ligament, and endothelial cells exhibited increased migration toward vCM compared to control cells that migrated in the absence of the matrix. Cellular adhesive properties on vCM were significantly increased compared to controls. Growth factors TGF-β1, PDGF-BB, FGF-2, and GDF-5 were adsorbed on vCM with great efficiency and continuously delivered in the medium after an initial burst release within hours. We observed statistically significant upregulation of genes encoding the antifibrinolytic thrombomodulin, plasminogen activator inhibitor type 1, thrombospondin 1, and thromboplastin, as well as strong downregulation of genes encoding the profibrinolytic tissue plasminogen activator, urokinase-type plasminogen activator, its receptor, and the matrix metalloproteinase 14 in cells grown on vCM. As a general trend, the stimulatory effect of the vCM on the expression of antifibrinolytic genes was synergistically enhanced by TGF-β1, PDGF-BB, or FGF-2, whereas the strong inhibitory effect of the vCM on the expression of profibrinolytic genes was reversed by PDGF-BB, FGF-2, or GDF-5. Taken together, our data strongly support the effect of the novel vCM on fibrin clot stabilization and coagulation/fibrinolysis equilibrium, thus facilitating progression to the next stages of the soft tissue healing process.     

Biomarkers for Cancer Cachexia: A Mini Review

Cancer cachexia is a common condition in many cancer patients, particularly those with advanced disease. Cancer cachexia patients are generally less tolerant to chemotherapies and radiotherapies, largely limiting their treatment options. While the search for treatments of this condition are ongoing, standards for the efficacy of treatments have yet to be developed. Current diagnostic criteria for cancer cachexia are primarily based on loss of body mass and muscle function. However, these criteria are rather limiting, and in time, when weight loss is noticeable, it may be too late for treatment. Consequently, biomarkers for cancer cachexia would be valuable adjuncts to current diagnostic criteria, and for assessing potential treatments. Using high throughput methods such as “omics approaches”, a plethora of potential biomarkers have been identified. This article reviews and summarizes current studies of biomarkers for cancer cachexia.